Effects of dexamethasone and alprazolam, a benzodiazepine, on the stimulatory effect of hexarelin, a synthetic GHRP, on ACTH, cortisol and GH secretion in humans

被引:46
|
作者
Arvat, E
Maccagno, B
Ramunni, J
Di Vito, L
Gianotti, L
Broglio, F
Benso, A
Deghenghi, R
Camanni, F
Ghigo, E
机构
[1] Univ Turin, Dept Internal Med, Div Endocrinol, Turin, Italy
[2] Europeptides, Argenteuil, France
关键词
corticotropin; growth hormone; adrenal steroids; growth hormone-releasing peptides; benzodiazepines; gamma-hydroxybutyric acid; clinical neuroendocrinology;
D O I
10.1159/000054328
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hexarelin (HEX) is a synthetic GHRP which acts on specific receptors at both the pituitary and the hypothalamic level to stimulate GH release both in animals and in humans. Like other GHRPs, HEX possesses also acute ACTH and cortisol-releasing activity similar to that of hCRH. The mechanisms underlying the stimulatory effect of GHRPs on hypothalamopituitary-adrenal (HPA) axis are still unclear, although a CNS-mediated action has been demonstrated. In 6 normal healthy young women (26-34 years) we studied the effects on ACTH and cortisol secretion of HEX (2.0 mu g/kg i.v. at 0 min) alone and preceded by dexamethasone (DEXA, 1 mg p.o. at 23.00 h on the previous night) or alprazolam (ALP, 0.02 mg/kg p.o. at -90 min), a benzodiazepine which binds to GABA receptors and possesses CRH-mediated inhibitory activity on HPA axis. ACTH and cortisol secretion after saline administration as well as the GH response to HEX alone and preceded by DEXA. or ALP were also studied. HEX administration elicited an increase in ACTH (peak vs, baseline, mean +/- SEM: 28.0 +/- 6.7 vs. 11.7 +/- 2.2 pg/ml, p < 0.05) and cortisol secretion (162.6 +/- 15.0 vs. 137.7 +/- 12.6 mu g/l, p < 0.05). DEXA pretreatment strongly inhibited basal ACTH (3.2 +/- 0.7 pg/ml, p < 0.01) and cortisol levels (11.3 +/- 2.5 mu g/l, p < 0.001) and abolished the ACTH and cortisol responses to HEX(3.6 +/- 0.9 pg/ml, p < 0.01 and 10.7 +/-: 2.0 mu g/l, p < 0.001), respectively. On the other hand, ALP pretreatment did not significantly modify basal ACTH (7.9 +/- 2.0 pg/ml) and cortisol levels(127.6 +/- 14.5 mu g/l) but abolished the HEX-induced ACTH and cortisol secretions (8.6 +/- 2.4 pg/ml, p < 0.05 and 111.0 +/- 6.0 mu g/l, p < 0.05), respectively. ACTH and cortisol levels after HEX when preceded by ALP overlapped with those recorded during saline. HEX induced a clear GH response (peak at 15 min vs. baseline: 65.5 +/- 20.5 vs. 2.2 +/- 0.7 mu g/l, p < 0.03) which was blunted by ALP (peak at 15 min: 21.5 +/- 5.5 mu g/l, p < 0.05) while it was not modified by DEXA pretreatment(78.7 +/- 7.6 mu g/l). In conclusion, our present data demonstrate that the ACTH-and cortisol-releasing effect of HEX is abolished by either dexamethasone or alprazolam, a benzodiazepine, which is even able to blunt the GH-releasing activity of the hexapeptide. These findings suggest that, in physiological conditions, the stimulatory effect of GHRPs on HPA axis is sensitive to the negative glucocorticoid feedback and could be mediated by GABAergic mechanisms; the latter seem also involved in the GH-releasing activity of GHRPs.
引用
收藏
页码:310 / 316
页数:7
相关论文
共 39 条
  • [1] Alprazolam, a benzodiazepine, blunts but does not abolish the ACTH and cortisol response to hexarelin, a GHRP, in obese patients
    S Grottoli
    E Arvat
    C Gauna
    B Maccagno
    J Ramunni
    R Giordano
    M Maccario
    R Deghenghi
    E Ghigo
    International Journal of Obesity, 2000, 24 : S136 - S137
  • [2] Alprazolam. a benzodiazepine, blunts but does not abolish the ACTH and cortisol response to hexarelin, a GHRP, in obese patients
    Grottoli, S
    Arvat, E
    Gauna, C
    Maccagno, B
    Ramunni, J
    Giordano, R
    Maccario, M
    Deghenghi, R
    Ghigo, E
    INTERNATIONAL JOURNAL OF OBESITY, 2000, 24 (Suppl 2) : S136 - S137
  • [3] Effects of the combined administration of hexarelin, a synthetic peptidyl GH secretagogue, and hCRH on ACTH, cortisol and GH secretion in patients with Cushing's disease
    Arvat, E
    Ramunni, J
    Giordano, R
    Maccagno, B
    Broglio, F
    Benso, A
    Deghenghi, R
    Ghigo, E
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1999, 22 (01) : 23 - 28
  • [4] Effects of the combined administration of hexarelin, a synthetic peptidyl GH secretagogue, and hCRH on ACTH, cortisol and GH secretion in patients with Cushing’s disease
    E. Arvat
    J. Ramunni
    R. Giordano
    B. Maccagno
    F. Broglio
    A. Benso
    R. Deghenghi
    E. Ghigo
    Journal of Endocrinological Investigation, 1999, 22 : 23 - 28
  • [5] Effects of GHRP-2 and hexarelin, two synthetic GH-releasing peptides, on GH, prolactin, ACTH and cortisol levels in man. Comparison with the effects of GHRH, TRH and hCRH
    Arvat, E
    diVito, L
    Maccagno, B
    Broglio, F
    Boghen, MF
    Deghenghi, R
    Camanni, F
    Ghigo, E
    PEPTIDES, 1997, 18 (06) : 885 - 891
  • [6] The inhibitory effect of alprazolam, a benzodiazepine, overrides the stimulatory effect of metyrapone-induced lack of negative cortisol feedback on corticotroph secretion in humans
    Arvat, E
    MacCagno, B
    Ramunni, J
    Di Vito, L
    Giordano, R
    Gianotti, L
    Broglio, F
    Camanni, F
    Ghigo, E
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (08): : 2611 - 2615
  • [7] Alprazolam, a benzodiazepine, does not modify the ACTH and cortisol response to hCRH and AVP, but blunts the cortisol response to ACTH in humans
    S. Grottoli
    B. Maccagno
    J. Ramunni
    L. Di Vito
    R. Giordano
    L. Gianotti
    S. Destefanis
    F. Camanni
    E. Ghigo
    E. Arvat
    Journal of Endocrinological Investigation, 2002, 25 : 420 - 425
  • [8] Alprazolam, a benzodiazepine, does not modify the ACTH and cortisol response to hCRH and AVP, but blunts the cortisol response to ACTH in humans
    Grottoli, S
    Maccagno, B
    Ramunni, J
    Di Vito, L
    Giordano, R
    Gianotti, L
    Destefanis, S
    Camanni, F
    Ghigo, E
    Arvat, E
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2002, 25 (05) : 420 - 425
  • [9] Effects of Alprazolam, a Benzodiazepine, on the ACTH-, GH- and PRL-Releasing Activity of Hexarelin, a Synthetic Peptidyl GH Secretagogue (GHS), in Patients with Simple Obesity and in Patients with Cushing's Disease
    Grottoli S.
    Arvat E.
    Gauna C.
    Maccagno B.
    Ramunni J.
    Giordano R.
    Maccario M.
    Deghenghi R.
    Ghigo E.
    Pituitary, 1999, 2 (3) : 197 - 204
  • [10] Nocturnal ghrelin, ACTH, GH and cortisol secretion after steep deprivation in humans
    Schuessler, P.
    Uhr, M.
    Ising, M.
    Weikel, J. C.
    Schmid, D. A.
    Held, K.
    Mathias, S.
    Steiger, A.
    PSYCHONEUROENDOCRINOLOGY, 2006, 31 (08) : 915 - 923